ILA 885.0
(-0.17%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | 8.18 Billion | 9.32 Billion |
Cost of Revenue | 715 Thousand | 696 Thousand | 857 Thousand | 1.12 Million | 1.85 Billion | 2 Million |
Gross Profit | -715 Thousand | -696 Thousand | -857 Thousand | -1.12 Million | 6.33 Billion | 9.31 Billion |
Operating Expenses | 1.37 Million | 2.03 Million | 467.02 Million | 37.96 Million | 6.65 Billion | 8.39 Billion |
Selling, General and Administrative Expenses | 536 Thousand | 563 Thousand | 634 Thousand | 7.45 Million | 2.41 Billion | 5.4 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 2.09 Million | 2.72 Million | 467.88 Million | 39.08 Million | 6.65 Billion | 8.39 Billion |
Operating Income | -1.25 Million | -1.25 Million | -1.49 Million | -8.58 Million | 1.08 Billion | -1.4 Billion |
Interest Expense | - | - | - | - | 539 Million | 540 Million |
Income Tax Expense | -575.00 | -1396.00 | 465.3 Thousand | - | 1.46 Billion | 40 Million |
Earnings before Tax | -1.82 Million | -2.65 Million | 463.81 Million | -474 Thousand | 457 Million | -1.98 Billion |
Net Income | -1.82 Million | -2.65 Million | 463.81 Million | -474 Thousand | -50 Million | -754 Million |
Earnings Per Share Basic | -0.83 | -1.20 | 298.08 | - | -44.64 Thousand | -673.21 Thousand |
Earnings Per Share Diluted | -0.83 | -1.20 | 298.24 | - | -44.64 Thousand | -673.21 Thousand |
Weighted Average Shares Outstanding | 2.2 Million | 2.2 Million | 1.55 Million | - | 1120.00 | 1120.00 |
Weighted Average Shares Outstanding (Diluted) | 2.2 Million | 2.2 Million | 1.55 Million | - | 1120.00 | 1120.00 |
Gross Margin | - | - | - | - | 0.77 | 1.00 |
EBIT Margin | - | - | - | - | 0.42 | 0.60 |
Profit Margin | - | - | - | - | -0.01 | -0.08 |
EBITDA | -575 Thousand | -1.39 Million | 465.3 Million | 1.88 Billion | 2.88 Billion | 5.61 Billion |
Earnings Before Tax Margin | - | - | - | - | 0.13 | -0.15 |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 715 Thousand | 186 Thousand | 186 Thousand | 171.5 Thousand | 171.5 Thousand | 696 Thousand |
Gross Profit | -715 Thousand | -186 Thousand | -186 Thousand | -171.5 Thousand | -171.5 Thousand | -696 Thousand |
Operating Expenses | 1.37 Million | 608 Thousand | 608 Thousand | 81.5 Thousand | 81.5 Thousand | 2.03 Million |
Selling, General and Administrative Expenses | - | 186.5 Thousand | 186.5 Thousand | 81.5 Thousand | 81.5 Thousand | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 2.09 Million | 794 Thousand | 794 Thousand | 253 Thousand | 253 Thousand | 2.72 Million |
Operating Income | -1.25 Million | -372.5 Thousand | -372.5 Thousand | -253 Thousand | -253 Thousand | -1.25 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -575.00 | 13.00 | 13.00 | -300.50 | -300.50 | -1396.00 |
Earnings before Tax | -1.82 Million | -359.5 Thousand | -359.5 Thousand | -553.5 Thousand | -553.5 Thousand | -2.65 Million |
Net Income | -1.82 Million | -359.5 Thousand | -359.5 Thousand | -553.5 Thousand | -553.5 Thousand | -2.65 Million |
Earnings Per Share Basic | - | -0.16 | -0.16 | -0.25 | -0.25 | - |
Earnings Per Share Diluted | - | -0.16 | -0.16 | -0.25 | -0.25 | - |
Weighted Average Shares Outstanding | 2.2 Million | 2.2 Million | 2.2 Million | 2.21 Million | 2.21 Million | 2.2 Million |
Weighted Average Shares Outstanding (Diluted) | 2.2 Million | 2.2 Million | 2.2 Million | 2.21 Million | 2.21 Million | 2.2 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | 13 Thousand | 13 Thousand | -300.5 Thousand | -300.5 Thousand | - |
Earnings Before Tax Margin | - | - | - | - | - | - |
3648
BETRF
AUROPHARMA
SMLR
4058
TW